A prediction model for blood-brain barrier penetrating peptides based on masked peptide transformers with dynamic routing

Abstract

Blood-brain barrier penetrating peptides (BBBPs) are short peptide sequences that possess the ability to traverse the selective blood-brain interface, making them valuable drug candidates or carriers for various payloads. However, the in vivo or in vitro validation of BBBPs is resource-intensive and time-consuming, driving the need for accurate in silico prediction methods. Unfortunately, the scarcity of experimentally validated BBBPs hinders the efficacy of current machine-learning approaches in generating reliable predictions. In this paper, we present DeepB3P3, a novel framework for BBBPs prediction. Our contribution encompasses four key aspects. Firstly, we propose a novel deep learning model consisting of a transformer encoder layer, a convolutional network backbone, and a capsule network classification head. This integrated architecture effectively learns representative features from peptide sequences. Secondly, we introduce masked peptides as a powerful data augmentation technique to compensate for small training set sizes in BBBP prediction. Thirdly, we develop a novel threshold-tuning method to handle imbalanced data by approximating the optimal decision threshold using the training set. Lastly, DeepB3P3 provides an accurate estimation of the uncertainty level associated with each prediction. Through extensive experiments, we demonstrate that DeepB3P3 achieves state-of-the-art accuracy of up to 98.31% on a benchmarking dataset, solidifying its potential as a promising computational tool for the prediction and discovery of BBBPs.

Artificial Intelligence with Great Potential in Medical Informatics: A Brief Review

“…As a potential therapeutic drug (Yan et al, 2022), toxin peptide (Monroe et al, 2023) has been developed with various AI models. In addition, there are corresponding AI models for other peptides, include antimicrobial peptide (Wang et al, 2016), anticancer peptide (Zhu et al, 2022), cell-penetrating peptide (Su et al, 2020), and blood-brain barrier penetrating peptide (Ma & Wolfinger, 2023).…”